Literature DB >> 2729407

Neural crest origin of human trabecular meshwork and its implications for the pathogenesis of glaucoma.

B J Tripathi1, R C Tripathi.   

Abstract

We used an immunohistochemical method to examine the distribution of neuronal-specific enolase in the trabecular meshwork of adult normal human eyes, as well as in primary cultures of human trabecular cells maintained in vitro for up to 44 days with or without the addition of nerve growth factor. In tissue sections of the globes, neuronal-specific enolase was present in the cells of the anterior region of the meshwork and those of the inner uveal beams. The cells of the posterior region of the meshwork stained variably with antiserum against neuronal-specific enolase. Cultured trabecular cells were initially neuronal-specific enolase-positive, but became negative after 18 to 21 days in vitro. The addition of nerve growth factor restored the expression of neuronal-specific enolase in these cultured cells. Because the presence of neuronal-specific enolase in normal cells is believed to indicate their differentiation from neuroectoderm, our results provide evidence that the trabecular cells in human eyes are derived from the embryonic neural crest. Our finding also supports the hypothesis that abnormal migration or a defective terminal induction of the neural crest cells has a role in certain ocular diseases that are characterized by chamber angle anomalies or primary glaucoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729407     DOI: 10.1016/0002-9394(89)90253-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  25 in total

1.  Basal nitric oxide production is enhanced by hydraulic pressure in cultured human trabecular cells.

Authors:  T Matsuo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Interaction of myocilin with gamma-synuclein affects its secretion and aggregation.

Authors:  Irina Surgucheva; Bum-Chan Park; Beatrice Y J T Yue; Stanislav Tomarev; Andrei Surguchov
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

3.  Lentiviral mediated gene delivery to the anterior chamber of rodent eyes.

Authors:  Pratap Challa; Coralia Luna; Paloma B Liton; Beth Chamblin; John Wakefield; Ram Ramabhadran; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2005-06-21       Impact factor: 2.367

4.  Senescence in cultured trabecular meshwork cells.

Authors:  Yukari Yamazaki; Hiroshi Matsunaga; Maki Nishikawa; Akira Ando; Shiho Kaneko; Koji Okuda; Mitsumasa Wada; Seiji Ito; Miyo Matsumura
Journal:  Br J Ophthalmol       Date:  2007-01-10       Impact factor: 4.638

Review 5.  Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations.

Authors:  Zeynep Tümer; Daniella Bach-Holm
Journal:  Eur J Hum Genet       Date:  2009-06-10       Impact factor: 4.246

6.  A comparative immunohistochemical study of human corneotrabecular tissue.

Authors:  B Foets; J van den Oord; K Engelmann; L Missotten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  Aberrant glycosylation in the human trabecular meshwork.

Authors:  Adam E Sienkiewicz; Brandon N Rosenberg; Genea Edwards; Teresia A Carreon; Sanjoy K Bhattacharya
Journal:  Proteomics Clin Appl       Date:  2014-03-07       Impact factor: 3.494

8.  Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids.

Authors:  Thania Bogarin; Sindhu Saraswathy; Goichi Akiyama; Xiaobin Xie; Robert N Weinreb; Jie Zheng; Alex S Huang
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 9.  Life under pressure: The role of ocular cribriform cells in preventing glaucoma.

Authors:  Jayter S Paula; Colm O'Brien; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2016-08-25       Impact factor: 3.467

Review 10.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.